UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049879
Receipt number R000056810
Scientific Title Efficacy, equivalence and operability of switching to a combination of budesonide, glycopyrronium, and formoterol in patients with COPD and ACO
Date of disclosure of the study information 2022/12/23
Last modified on 2022/12/23 02:09:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy, equivalence and operability of switching to a combination of budesonide, glycopyrronium, and formoterol in patients with COPD and ACO

Acronym

Efficacy, equivalence and operability of switching to a combination of budesonide, glycopyrronium, and formoterol in patients with COPD and ACO

Scientific Title

Efficacy, equivalence and operability of switching to a combination of budesonide, glycopyrronium, and formoterol in patients with COPD and ACO

Scientific Title:Acronym

Efficacy, equivalence and operability of switching to a combination of budesonide, glycopyrronium, and formoterol in patients with COPD and ACO

Region

Japan


Condition

Condition

COPD

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

An observational study of efficacy, adverse events, inhalation maneuverability, and adherence before and after switching to Breztri (a combination of budesonide, glycopyrronium, and formoterol) in patients with COPD or ACO requiring an corticosteroid, long-acting beta 2 agonist, and long-acting muscarinic antagonist.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

Efficacy, adverse events, inhalation maneuverability, and adherence before and after switching to Breztri (a combination of budesonide, glycopyrronium, and formoterol) in patients with COPD or ACO requiring an ICS, LABA, and LAMA.

Key secondary outcomes

Comparison with Trelegy in patients switching from Trelegy


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Breztri for patients requiring ICS, LABA, or LAMA

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

COPD or ACO patients requiring ICS, LABA and LAMA
Patients who can give consent

Key exclusion criteria

1) Under 40 years old
2) Patients who have difficulty inhaling by theirself
3) Patients for whom the physician determines that pulmonary function testing is impossible or inaccurate for any reason (e.g., hearing loss, pregnancy, etc.)
4) Patients whose QoL or lung function may be affected during the study period, as determined by the physician: e.g., patients with end-stage cancer, severe heart failure, liver cirrhosis, respiratory failure, etc.
5) Patients who cannot use ICS or LABA or LAMA

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Masato
Middle name
Last name Muraki

Organization

Kindai University Nara Hospital

Division name

Department of Respiratory Medicine and Allergology

Zip code

630-0293

Address

1248-1 Otoda-cho, Ikoma, Nara 630-0293, Japan

TEL

0743-77-0880

Email

muraki-m@med.kindai.ac.jp


Public contact

Name of contact person

1st name Masato
Middle name
Last name Muraki

Organization

Kindai University Nara Hospital

Division name

Department of Respiratory Medicine and Allergology

Zip code

630-0293

Address

1248-1 Otoda-cho, Ikoma, Nara 630-0293, Japan

TEL

0743-77-0880

Homepage URL

https://www.med.kindai.ac.jp/nara/

Email

muraki-m@med.kindai.ac.jp


Sponsor or person

Institute

Kindai University Nara Hospital

Institute

Department

Personal name

Masato Muraki


Funding Source

Organization

Kindai University Nara Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kindai University Nara Hospital

Address

1248-1 Otoda-cho, Ikoma, Nara 630-0293, Japan

Tel

0743-77-0880

Email

muraki-m@med.kindai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

近畿大学奈良病院


Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 11 Month 20 Day

Date of IRB

2020 Year 12 Month 07 Day

Anticipated trial start date

2020 Year 12 Month 07 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 12 Month 23 Day

Last modified on

2022 Year 12 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056810


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name